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Abstract
Background: The authors tested the hypothesis that depression is a possible factor influencing
the course of cancer by reviewing prospective epidemiological studies and calculating summary
relative risks.
Methods: Studies were identified by computerized searches of Medline, Embase and PsycINFO.
as well as manual searches of reference lists of selected publications. Inclusion criteria were cohort
design, population-based sample, structured measurement of depression and outcome of cancer
known for depressed and non-depressed subjects
Results: Thirteen eligible studies were identified. Based on eight studies with complete crude data
on overall cancer, our summary relative risk (95% confidence interval) was 1.19 (1.06–1.32). After
adjustment for confounders we pooled a summary relative risk of 1.12 (0.99–1.26).
No significant association was found between depression and subsequent breast cancer risk, based
on seven heterogeneous studies, with or without adjustment for possible confounders. Subgroup
analysis of studies with a follow-up of ten years or more, however, resulted in a statistically
significant summary relative risk of 2.50 (1.06–5.91).
No significant associations were found for lung, colon or prostate cancer.
Conclusion: This review suggests a tendency towards a small and marginally significant association
between depression and subsequent overall cancer risk and towards a stronger increase of breast
cancer risk emerging many years after a previous depression.
Introduction
Whether or not depression might be a risk factor for devel-
oping cancer has long been debated. Reports on the rela-
tion between depression and cancer risk are controversial
and mixed. Most of these studies are not designed to
describe a directional and certainly not a cause and effect
relationship. From 1980 onwards several prospective
studies have been published and in 1994 a meta-analysis
on the subject was conducted [1]. In this meta-analysis the
pooled overall odds ratio between depression and subse-
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quent cancer risk was 1.14 (95% confidence interval:
0.99–1.30), which led the authors to conclude to a small
and marginally significant association between depres-
sion and the subsequent development of cancer. The stud-
ies included in the meta-analyses were all published
between 1980 and 1990 and possible confounders were
not taken into account during pooling. After the publica-
tion of this meta-analysis several similar studies were pub-
lished. We therefore decided to perform a new systematic
review to investigate whether the conclusion about
depression being a risk factor for cancer development still
holds, taking into account the effect of possible confound-
ers and concentrating on general population-based stud-
ies only.
Methods
Literature search
Our start for selecting studies was the meta-analysis by
McGee et al. published in 1994 [1]. The studies included
in this meta-analysis were identified and their references
were checked for additional relevant publications. We
searched Medline, Embase and PsycINFO from 1990 to
the end of October 2005 with a highly sensitive search
strategy using the keywords depress* in combination with
neoplasm* or cancer. Searches were independently per-
formed by three individual researchers of which two are
experienced meta-analysts. Their yields were added to one
common list of references. Reference lists from identified
prospective studies were also checked for other potentially
relevant publications not included in the computerized
database search and we contacted leading experts in this
field as well as researchers we knew to be engaged in
recent studies.
Selection and data collection
Final inclusion was based on the following selection crite-
ria: a prospective, general population-based study, which
made use of validated measures of depression as well as
questionnaires that resembled Diagnostic Statistical Man-
ual of mental disorders (DSM) criteria for major depres-
sion. Studies, in which the diagnosis of depression was
based on the subjective judgment of a clinician only, or
on the presence of a certain number of symptoms, were
not included. We did not use any language restriction.
Also publications included in the meta-analysis by McGee
et al. [1] were checked according to our own criteria. As a
result only four of the seven studies identified by McGee
et al. [1] were included in our own meta-analysis.
Quality assessment
For each study, data were collected on several study char-
acteristics (continent, setting, age range, sex ratio, depres-
sion assessment method, method of retrieval of the cancer
cases, years of follow-up, type of cancer, and number of
cancer patients). Data extraction was performed by one
researcher and supervised by at least one senior
researcher.
Analysis
From each study we constructed 2 × 2 tables in order to
calculate crude relative risks. If the published study did
not provide the data needed for the 2 × 2 table, we tried to
contact the corresponding author to complete our tables.
Publication bias was examined by means of a funnel plot.
We examined asymmetry visually and measured the
degree of asymmetry by using Egger's unweighted regres-
sion asymmetry test [2].
For all associations, we examined the presence of hetero-
geneity visually by inspecting forest plots. Presence of het-
erogeneity was also quantified. We calculated a chi-square
test for homogeneity, an I2 as a measure of the percentage
of total variations across studies that is due to heterogene-
ity rather than chance and the estimate of between studies
variance, calculated by comparing the results of fixed and
random effect pooling of the same sets of studies. For rea-
sons of readability we only report the I2 as it turned out to
be the most powerful in detecting heterogeneity [3]. I2 val-
ues of 25%, 50% and 75% are considered to indicate low,
moderate and high heterogeneity. To explore reasons for
heterogeneity we performed subgroup analyses. As we
considered length of the follow-up period and adjustment
for smoking behavior as likely being the most important
confounders, we included subgroup analyses according to
these variables if a sufficient number of studies were avail-
able.
Meta-analyses were performed for depression and overall
cancer risk and for the risk of individual types of cancer
after depression, as long as at least three studies were
available. In order to be able to include studies with no
depressed cancer case in our pooling, we added 0.5 to
each cell of the 2 × 2 table for these studies.
Crude data pooling included all studies for which the
crude RR and 95% confidence interval were available or
could be calculated. Pooling of adjusted risks included all
studies, which were at least adjusted for age. Summary
odds ratios and corresponding confidence intervals, were
calculated based on random effect modeling. We used the
Meta command of STATA version 8.0 software [4] for all
calculations except the I2 which was calculated by hand,
according to the formula published by Higgins et al [3].
Results
The review of McGee provided 7 studies [5-11]. After
applying our selection criteria we included 4 of these stud-
ies [8-11]. One study was not included because only vol-
unteers from a particular workplace [6] were investigated,Clinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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and one study was excluded because the measuring instru-
ment for depression only produced scores without a cut-
point and was not clearly described. Its validity could
therefore not be evaluated [5]. The third study was
excluded because the depression status at baseline was
only based on one single question [7].
The computerized search strategy revealed ten publica-
tions from 1990 onwards [12-21]. Furthermore, we found
two additional research reports that were only available as
reports and not as published papers [22,23].
After applying the selection criteria, another nine studies
were included in our meta-analysis. One study was not
included because only psychiatric clinic patients were
investigated [12]. Another study was excluded because
depression was based on the subjective judgment of a cli-
nician [13]. The last study was excluded because the
depression status at baseline was only based on one single
question [14].
Finally we included data of 13 studies [8-11,15-23] and
127,840 patients in our review. Nine studies provided
data on the relation between depression and subsequent
overall cancer, of which eight presented sufficient infor-
mation to enable crude data meta-analysis and seven to
enable meta-analysis of adjusted study results. Some of
these studies also provided data on subgroups of individ-
ual cancer localizations, especially breast, lung, prostate
or colon cancer. For studies only provided data on breast
cancer and not on overall cancer.
In table 1 the descriptive characteristics of the selected
studies are shown. Five studies were conducted in Europe
[17,18,21-23], all other studies took place in the USA [8-
11,15,16,19,20]. The smallest study involved 1,213 sub-
jects [16], the largest study involved 68,366 subjects [23].
In most studies it was formally stated that cancer-free sub-
jects (either all cancers or specific cancer sites) only were
eligible for follow-up [8,9,11,15,17-19,21,23]. For four
studies, however, this was not clearly stated
[10,16,20,22]. One study only included subjects aged 70
and over [19] and one study only included women aged
56–62[18]. The other studies had a wide range of ages
included.
Three studies applied the Center for Epidemiologic Stud-
ies-Depression (CES-D) scale for measurement of depres-
sion[10,11,19]. Other questionnaires used were the
Minnesota Multiphasic Personality Inventory (MMPI) [9],
the Human Population Laboratory-Depression scale
(HPL) [8], the General Well-being schedule, Cheerful vs.
Depressed mood scale (GWB-D) [10], the Present State
Examination (PSE) [17], the Diagnostic Interview Sched-
ule (DIS) [17], the Beck Depression Inventory (BDI) [21],
the Edinburgh Depression Scale (EDS) [18] and the
ICHPPC-2 criteria [22,23] which come close to the DSM-
IV criteria. In one study questions were used that allowed
for a close approximation of the clinical definition of
depression according to DSM-III[20].
Three studies had a short follow-up of 4–9
years[18,19,21], while the remainder of studies had
between 10 and 25 years of follow-up [8-11,15-
17,20,22,23]. The percentage of cancer cases in the study
samples varied between 1.1% [16] and 10.7%[8]. In one
study this could not be calculated[20]. Definition of can-
cer was generally based on hospital records, cancer regis-
tries, death certificates or a combination of these. Only in
one study it was stated that all diagnoses were histologi-
cally confirmed[9].
Data for the 2 × 2 tables were complete for seven studies
on overall cancer risk [10,11,15,17,19,22,23], for six stud-
ies on breast cancer risk [9,15-19,23], and for three studies
on lung cancer risk [17,19,23].
• Overall cancer
In table 2 the crude and adjusted relative risks for subse-
quent cancer occurrence in patients with and without
depression are presented.
Publication bias
Using Egger's unweighted regression asymmetry test we
found no evidence for publication bias (p = 0.34).
Heterogeneity
Neither visual examination of the forest plot nor the
quantitative test provided evidence for heterogeneity of
the crude data results (I2<0.01).
Statistical pooling
Statistical pooling of the eight studies on overall cancer
risk after depression revealed an estimated crude sum-
mary relative risk (95% CI) of 1.19 (1.06–1.32).
After correction for the confounding factors selected by
the original authors (even if this is for age or age and sex
only), all seven selected studies reported statistically non-
significant associations around the null value
[10,11,15,17,20,23] except for one study, which reported
a statistically significant association between chronic
depression and cancer [19]. Statistical pooling revealed an
estimated adjusted summary relative risk of 1.12 (0.99–
1.26).
Subgroup analysis on studies that adjusted for smoking or
had a follow-up period of ten years or more did not
change this picture.Clinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
Page 4 of 11
(page number not for citation purposes)
Table 1: Descriptive characteristics of included prospective studies on depression and subsequent cancer occurrence
First author 
(ref)
Total sample 
(% women)
Setting of 
cohort
Site of cancer Age Range Depression 
questionnaire
Diagnosis Follow-up 
(years)
Number of 
total cancer 
patients (% on 
total)
Hahn (9) 8,932 (100) Breast 
cancer-free 
subjects
Breast only ns MMPI 
depession 70
Medical 
records and 
Histology
1969–1982 
(13)
120 (1.3%)
Kaplan (8) 6,848 (?) Population 
sample, 
cancer-free 
subjects
All Lung, 
Breast 
Prostate, 
Colon
"adults" HPL Cancer 
registry
1965–1982 
(17)
733 (10.7%)
Zonderman 
(10)
6,403 (?) Population 
sample
All 25–75 CES-D (cut-
off score 16) 
GWB-D (cut 
off score 13)
Hospitalizatio
n records and 
death 
certificates
1971–1981 
(10)
637 (9.9%)
Linkins (11) 2,264 (?) Population 
sample, 
cancer-free 
subjects
All >18 CES-D 
(depression 
16)
Cancer 
registry and 
death 
certificates
1975–1987 
(12)
169 (7.5%)
Vogt (20) 1,529 (?) Population 
sample
All ≥ 18 DSM-III based 
questionnaire
Death 
certificates 
and state of 
vital records
1970–1985 
(15)
?
Knekt (17) 7,018 (55) Population 
sample, 
cancer-free 
subjects
All Lung, 
Breast
30–95 PSE, Cancer 
registry
1978–1991 
(14)
605 (8.6%)
Penninx (19) 4,825 (64.6) Population 
sample, 
cancer-free 
subjects
All 11 sites 71–96 CES-D Hospitalizatio
n records and 
death 
certificates
1988–1992 
(7)
402 (8.3%)
Gallo (15) 2,017 (60) Population 
sample, 
cancer-free 
subjects
All Lung, 
Breast, Skin, 
Colon, 
Prostate
>18 DIS Self reports 
and death 
certification
1981–1994 
(13)
203 (10.1%)
van den 
Heuvel (22)
2,342 (?) GP-based All All GP diagnosis 
ICHPPC-2 
criteria
GP-registry 1984–1994 
(10)
76 (3.2%)
Schuurman 
(23)
68,366 
(51.2%)
GP-based 
cancer-free 
subjects
All Lung, 
breast, colon, 
prostate
≥ 20 GP diagnosis 
ICHPPC-2 
criteria
GP-registry 1975–2000 
(25)
3,464 (5.1%)
Jacobs (16) 1,213 Population 
sample
Breast Mean = 43 DIS Hospitalizatio
n (self report)
1980–1995 
(15)
58 (1.1%)
Nyklicek (18) 5,191 Population 
sample, 
cancer-free 
subjects
Breast 56–62 EDS Cancer 
registry
1995–2000 
(5)
39(3.2%)
Aro(21) 10,892 Population 
sample, 
breast 
cancer-free 
subjects
Breast 48–50 BDI Cancer 
registry
1992–2001 
(6–9)
278(2.6%)
MMPI: Minnesota Multiphasic Personality Inventory
DIS: Diagnostic Interview Schedule
HPL: Human Population Laboratory-Depression scale
ICHPPC-2: International Classification of Health Problems in Primary Care
CES-D: Center for Epidemiologic Studies-Depression scale
EDS: Edinburgh Depression Scale
GWB-D: General Well-being schedule, Cheerfull vs Depressed mood scale
BDI: Beck Depression Inventory
PSE: Present State Examination
ns: not specifiedClinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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￿ Breast cancer
Nine studies reported results for breast cancer separately
[8,9,15-19,23] (table 3). Five studies are subgroup analy-
ses of a larger study that also was included in the overall
cancer analysis [8,15,17,19,23]. Four studies, however,
only examined the association between depression and
subsequent breast cancer in females and are not included
in the overall cancer analysis [9,16,18,21].
Crude relative risks varied widely between 0.11 [18] and
7.28 [16]. It should be mentioned that both studies with
a relative risk below 1.0 [18] had the shortest follow-up
time (5 and 6 years respectively, while in other studies fol-
low-up times of at least 10 years were used).
Publication bias
Using Egger's unweighted regression asymmetry test we
found no evidence for publication bias (p = 0.85)
Heterogeneity
Both visual examination of the forest plot as well as the
quantitative tests suggested heterogeneity of both the
crude data (I2 = 0.37) and the adjusted (I2 = 0.37) results.
Statistical pooling
Statistical pooling of the seven studies with sufficient
crude data for breast cancer resulted in an estimated sum-
mary relative risk of 1.46 (0.80–2.64). Eight studies pro-
vided adjusted relative risks. The summary relative risk
Table 2: Results from prospective studies on depression and subsequent overall cancer occurrence
First author 
(ref)
Number of subjects with 
depression
Number of subjects without 
depression
Total 
numbers of 
subjects
Crude RR 
(95% CI)
Multivariable 
Adjusted RR 
(95% CI) 
reported in 
paper
Adjustment 
factors for 
multivariable 
RR
Cancer No cancer Cancer No Cancer
Kaplan (8) 117 N.a. 612 N.a. 6,848 - 0.97 males 
1.27 females
Age, sex
Zonderman 
(10)
110 892 527 4,874 6,403 1.13 (0.93–
1.37)
1.1 (0.9–1.4) Age, sex, 
marital status, 
smoking, 
family history 
of cancer, 
hypertension, 
cholesterol 
level
Linkins (11) 25 343 144 1,752 2,264 0.89 (0.59–
1.35)
1.09 (0.69–
1.71)
Age
Vogt (20) N.a. N.a. N.a. N.a. 1,529 1.08 (0.79–
1.49)
1.08 (0.77–
1.52)
Age, sex, 
social class, 
Smoking, 
duration of 
health plan 
membership
Knekt (17) 29 295 486 5,298 7,018 1.07 (0.75–
1.52)
0.99 (0.68–
1.44)
Age, sex
Penninx (19) 16 130 386 4293 4825 1.33 (0.83–
2.13)
1.88 (1.13–
3.14)
Age, sex, 
race, 
disability, 
hospital 
admissions, 
alcohol, 
smoking
Gallo (15) 8 82 141 1,338 1,569 0.93 (0.47–
1.84)
1.3 (0.6–2.8) Age, sex, 
smoking, 
alcohol
van den 
Heuvel (22)
9 207 67 2,059 2,342 1.32 (0.67–
2.61)
n.a.
Schuurman 
(23)
95 1,246 3,369 63,656 68,366 1.41 (1.16–
1.72)
1.08 (0.88–
1.33)
Age, sex, 
socioeconomi
c statusClinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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was 1.59 (0.74–3.44). In a sensitivity analysis we excluded
the three studies with the smallest follow-up time
[18,19,21] and kept the five studies with at least ten years
of follow-up. Heterogeneity remained high (I2 = 0.74). All
studies had adjusted relative risks above 1.0, and the esti-
mated adjusted summary risk ratio was 2.50 (1.06–5.91).
In two studies results were adjusted for smoking. These
studies showed an I2 of 0.88 and a summary adjusted rel-
ative risk of 1.72 (0.33–9.01).
￿ Lung cancer
Five studies reported results on lung cancer after depres-
sion [8,15,17,19,23] (table 4).
One study provided a relative risk without a confidence
interval [8]. For men and women combined, two studies
reported a non-significant positive association[19,23] and
one study reported a non-significant negative associa-
tion[15]. For men only, one study also reported a non-sig-
nificant positive association[17]. It has to be noticed that
the estimated relative risks in most studies were based on
very small numbers of depressed patients.
Publication bias
Using Egger's unweighted regression asymmetry test we
found no evidence for publication bias (p = 0.51)
Table 3: Results from prospective studies on depression and subsequent breast cancer occurrence
First author 
(ref)
Number of subjects with 
depression
Number of subjects without 
depression
Crude RR (95% 
CI)
Multivariable 
adjusted RR 
(95% CI) 
reported in 
paper
Adjustment 
factors for 
multivariable 
RR
Cancer No cancer Cancer No cancer
Hahn (9) 15 821 105 7,991 1.38 (0.81–2.37) 1.5 (0.9–2.5) Age, nulliparity, 
obesity, 
hysterectomy
Kaplan (8) N.a. N.a. N.a. N.a. - 1.13 (incidence) Age
Knekt (17) 7 203 47 2,976 2.14 (0.98–4.68) 1.96 (0.88–4.33) Age
Penninx (19) 0 575 31 3806 0.11 (0.01–1.73) No depressed 
cases of 
malignancy
Age, race, 
disability, 
hospital 
admissions, 
alcohol, 
smoking
Gallo (15) 3 N.a. 22 N.a. 3.1 (0.9–11.02) 3.8 (1.0–14.3) Age, smoking, 
alcohol
Schuurman (23) 25 830 703 32,746 1.39 (0.94–2.06) 1.06 (0.71–1.58) Age, socio-
economic status
Jacobs (16) 2 9 38 1484 7.28 (2.0–26.52) 17.2 (3.76–
77.08)
Age, family 
history of 
breast cancer, 
chronic illness 
at follow-up, 
income
Nyklicek (18) 3 837 54 4297 0.29 (0.09–0.92) 0.29 (0.09–0.91) Family history 
breast cancer, 
menopause, 
oophorectomy, 
hypothyroidism
Aro (21) 0.70 (0.07–1.63) Area of 
residence, age, 
education, 
income, 
children, 
socioeconomic 
status, familiy 
history of 
breast cancer, 
smoking, 
alcohol, physical 
exerciseClinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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Heterogeneity
Neither visual examination of the forest plot nor the
quantitative tests provided evidence for heterogeneity of
the crude data results (I2<0.01).
Statistical pooling
Combining the results of the four studies resulted in an
estimated crude summary relative risk of 1.40 (0.90–
2.17). After correction for potential confounding factors
by the original authors, no statistically significant associa-
tions were seen. Statistical pooling revealed an estimated
summary relative risk of 1.37 (0.88–2.16), based on four
studies [15,17,19,23].
Separate meta-analyses for studies with a follow-up
period of ten years or more RR= 1.31; 0.82–2.11) and for
studies adjusting for smoking behavior (RR = 1.67; 0.50–
5.38) gave comparable results.
￿ Colon cancer
Four studies reported results on depression and subse-
quent risk of colon cancer [8,15,19,23] (table 5). Non-sig-
nificant changes were reported in three studies [8,19,23].
In the fourth study there were no subjects with colon can-
cer among the depressives [15].
Statistical pooling
Statistical pooling could not be performed due to insuffi-
cient data.
￿ Prostate cancer
Three studies reported results on depression and subse-
quent risk of prostate cancer [15,19,23]. (table 6)
Publication bias
Using Egger's unweighted regression asymmetry test we
found no evidence for publication bias.
Heterogeneity
Heterogeneity was tested using the adjusted data results
(see table 7), because only two studies presented com-
plete crude data. Both visual examination of the forest
plot, and the quantitative tests provided evidence for
moderate heterogeneity (I2 = 0.55).
Statistical pooling
After adjustment for potential confounders three studies
reported an increased cancer risk [15,19], one found a
non-significant decreased risk [23]. Statistical pooling
revealed an estimated summary adjusted relative risk of
1.60 (0.40–6.50).
￿ Other cancers
Two studies reported results on depression and subse-
quent risk of skin cancer [15,19] and two studies reported
results on depression and subsequent risk of non-prostate
urinary tract cancer [15,19,23]. All reported a non-signifi-
cant association.
For no other cancer localization more than one study
provided results.
Table 4: Results from prospective studies on depression and subsequent lung cancer occurrence
First author 
(ref)
Number of subjects with 
depression
Number of subjects without 
depression
Crude RR (95% 
CI)
Multivariable 
adjusted RR 
(95% CI) 
reported in 
paper
Adjustment 
factors for 
multivariable 
RR
Cancer No cancer Cancer No cancer
Kaplan (8) N.a. N.a. N.a. N.a. - 1.33 incidence 
males 1.09 
incidence fem
Age, sex
Knekt (17) 4 110 53 2708 1.83 (0.67–4.96) 1.65 (0.60–4.58) Age, sex (only 
males)
Penninx (19) 2 144 54 4,625 1.19 (0.29–4.82) 2.10 (0.49–8.92) Age, sex, race, 
disability, 
hospital 
admissions, 
alcohol, 
smoking
Gallo (15) N.a. N.a. N.a. N.a. 0.7 (0.1–5.1) 1.0 (0.1–7.7) Age, sex, 
smoking, 
alcohol
Schuurman (23) 13 1,328 466 66,559 1.39 (0.81–2.41) 1.25 (0.72–2.17) Age. Sex, socio-
economic statusClinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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Discussion
￿ Results
We summarized study results from 13 prospectively
designed and general-population-based studies on
depression and the subsequent risk of cancer. For overall
cancer, statistical pooling revealed a summary relative risk
(95%CI) of 1.19 (1.06–1.32) at crude data analysis
(based on eight studies with complete data) and 1.12
(0.99–1.26) after adjustment for potential confounders
(seven studies). Five studies adjusted for more possible
confounders than age and sex only [10,15,19,20,23].
These studies gave a similar result (summary relative risk
= 1.14; 0.99–1.31). Also subgroup analyses including
only studies adjusting for smoking (1.20) or studies with
a follow-up of ten years or more (1.09) gave similar and
non-significant summary relative risks. One of the eight
available studies could not be included in our pooled esti-
mate of adjusted overall cancer risk after depression
because of insufficient information [8]. However, inclu-
sion of this study would probably not have resulted in a
different summary relative risk since it reported an associ-
ation that was near to our pooled result.
No significant association was found between depression
and subsequent breast cancer risk, based on seven hetero-
geneous studies, with or without adjustment for possible
confounders. Subgroup analysis on studies with and with-
out adjustment for smoking behavior did not change the
picture. Subgroup analysis with a follow-up time of ten
years or more, however, resulted in a statistically
Table 5: Results from prospective studies on depression and subsequent colon cancer occurrence
First author 
(ref)
Number of subjects with 
depression
Number of subjects without 
depression
Crude RR (95% 
CI)
Multivariable 
adjusted RR 
(95% CI) 
reported in 
paper
Adjustment 
factors for 
multivariable 
RR
Cancer No cancer Cancer No cancer
Kaplan (8) N.a. N.a. N.a. N.a. - 0.34 (males) 
1.08 (females)
Age, sex
Penninx (19) N.a. N.a. N.a. N.a. - 1.37 (0.33–5.74) Age, sex, race, 
disability, 
hospital 
admissions, 
alcohol, 
smoking
Gallo (15) 0 N.a. 19 N.a. No cases No cases Age, sex, 
smoking, 
alcohol
Schuurman (23) 14 1,327 568 66,457 1.23 (0.73–2.09) 0.93 (0.55–1.58) Age, sex, socio-
economic status
Table 6: Results from prospective studies on depression and subsequent prostate cancer occurrence
First author 
(ref)
Number of subjects with 
depression
Number of subjects without 
depression
Crude RR (95% 
CI)
Multivariable 
adjusted RR 
(95% CI) 
reported in 
paper
Adjustment 
factors for 
multivariable 
RR
Cancer No cancer Cancer No cancer
Penninx (19) N.a. N.a. N.a. N.a. - 1.47 (1.01–
22.79)
Age, race, 
disability, 
hospital 
admissions, 
alcohol, 
smoking
Gallo (15) N.a. N.a. N.a. N.a. 3.6 (0.4–31.3) 11.8 (1–144.3) Age, smoking, 
alcohol
Schuurman (23) 3 1338 263 66762 0.57 (0.18–1.78) 0.65 (0.21–2.05) Age, socio-
economic statusClinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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significant summary relative risk of 2.50, which would be
a strong extra risk.
No significant associations were found for lung, colon or
prostate cancer.
￿ Evidence from other studies
The results of our meta-analysis suggest a small but
increased risk for overall cancer after depression. This is
consistent with the marginally significant association
(1.14; 0.99–1.30) that was earlier described in the previ-
ous review by Mc Gee et al in 1994 [1]. They included far
less studies than in our review, some of their studies were
not general population-based, they did not perform any
of the subgroup analyses we performed and they did not
analyze the association with individual cancer locations.
￿ Review limitations
No less than ten different questionnaires were used for the
measurement of depression in the 13 studies. This prob-
lem adds to the multiple conceptual problems concerned
with the definition of depression[24]. Since there were
only three studies in which the same questionnaire was
used, we could not stratify results according to the meas-
urement instrument that was used to diagnose depres-
sion. However, differences in reported results may
originate from the use of these different instruments.
It is possible that our findings result from random error.
After all we performed a lot of tests. However, our results
seem plausible and consistent and even the non-signifi-
cant results point in the same direction. Of all individual
study results on overall and breast cancer that we used for
pooling only three had an adjusted relative risk below 1.0.
Between-study heterogeneity may also result from differ-
ences in the sets of potential confounding factors that
have been adjusted for in multivariable analyses. In some
cases we are not sure that the list of co-variables that were
reported in the multivariate model, were the complete set
of variables that was collected. We cannot exclude that
more variables were stepwise removed during model
building and that only significant ones were reported.
On the basis of the data reported in table 1, we roughly
estimated the yearly cancer incidence rates per study. For
overall cancer they range between 2 and 12 per 1,000
patient-years. Although this is a broad range, they seem to
follow a Gaussian curve and there are no real outliers. For
the four studies which focus on breast cancer only, the
rates are closer to each other (1 to 6 per 1,000 patient-
years).
Neither for overall cancer nor for breast cancer risk we
have reason to expect that our results are biased by one
study with an extreme high or low relative risk. For overall
cancer, all results are quite near to each other and for
Table 7: Relationship between depression and subsequent cancer: summary of the review results
Number of studies Summary relative risk (95% CI) Heterogeneity (I2)
Overall cancer
Crude 8 1.19 (1.06–1.32) <0.01
Multivariate 7 1.12 (0.99–1.26) <0.01
Studies adjusting for smoking 4 1.20 (0.97–1.49) 0.23
Studies with follow-up > 10 
years
6 1.08 (0.96–1.22) <0.01
Breast cancer
Crude 7 1.46 (0.80–2.64) 0.37
Multivariate 8 1.59 (0.74–3.44) 0.37
Studies adjusting for smoking 2 1.72 (0.33–9.01) 0.88
Studies with follow-up > 10 
years
5 2.50 (1.06–5.91) 0.74
Lung cancer
Crude 4 1.40 (0.90–2.17) <0.01
Multivariate 4 1.37 (0.88–2.16) <0.01
Studies adjusting for smoking 2 1.67 (0.50–5.38) <0.01
Studies with follow-up > 10 
years
3 1.31 (082–2.11) <0.01
Prostate cancer (adjusted) 3 1.60 (0.40–6.50) 0.55Clinical Practice and Epidemiology in Mental Health 2007, 3:29 http://www.cpementalhealth.com/content/3/1/29
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breast cancer the studies with both the highest [16] and
lowest [18] relative risk have low to moderate sample
sizes. In both cases, the study with the highest sample size
[23] tends to decrease the magnitude of the association. In
case this study would be to influential, the 'real' associa-
tion would therefore even be larger.
￿ Mechanisms explaining association
We can only speculate about mechanisms explaining a
possible association between depression and subsequent
risk of cancer. Risk factors for cancer tend to be active long
before the occurrence of the first signs. This complies with
our finding that the increased breast cancer risk only
became apparent in studies with a follow-up of ten years
or more. At the other hand it may be possible that depres-
sion is an indicator or a consequence of other changes in
the body that are the first steps in the oncogenesis. A sim-
ilar pattern was found in the positive association between
herpes zoster and subsequent cancer in older people that
only emerges after the first year and increases with time
[25], and between postmenopausal hormone therapy and
breast cancer after four years[26].
It has been suggested that depression affects the immune
and hormonal system [27]. It may so alter the body's
defense systems against cancer. In the past an increased
risk of Parkinson's disease after depression was suggested
to be associated with a common etiological base [28].
However, in our review the studies with a short follow-up
time reported no increased risk of depression for develop-
ing cancer.
It could also be hypothesized that both depression and
increased cancer risk could be related to the presence of
one or more genetic characteristics that may be either
common or very nearly located in the genome. For the
time being, we have no evidence, however, to support this
latter hypothesis.
It could also be argued that women experiencing depres-
sion at early ages are less likely to have a large number of
children, thereby increasing their breast cancer risk.
Alcohol intake [29] and smoking [30] may have an effect
on the relation between depression and cancer risk. Such
effect may either be called confounding or a step in the eti-
ological path from depression resulting in increased
smoking or drinking and finally increased cancer risk.
However, in our review we did not find any significant dif-
ference between studies that adjusted for smoking and
those that did not.
In the past, experimental studies have suggested that anti-
depressant drugs may increase cancer risk or promote
tumor growth [31,32]. Lawlor et al. performed a system-
atic review on the epidemiologic and trial evidence of an
association between antidepressant drugs and breast can-
cer. Pooled data from 31 primary efficacy drug company
trials of fluoxetine suggested no increased risk, but the
short duration of these trials may have been insufficient to
detect an association [33]. The authors also included 5
cohort studies. One prospective study found an increased
breast cancer risk after adjustment for a number of poten-
tial confounding factors. The other studies reported no
significant association. In 2003 another review collected
data from six studies on antidepressant drugs and breast
cancer risk. Several studies reported that certain antide-
pressant drugs may be associated with a slightly increased
breast cancer risk, however literature was inconsistent.
Methodological limitations of these studies include lack
of adjustment for potential confounders, lack of informa-
tion on duration of use and limited sample sizes [34]. The
most recent review we found suggests that antidepressant
use might increase the risk of breast cancer, because some
psychotropic drugs raise prolactine levels and some spe-
cific antidepressants acted as tumor promoters in rodents.
However, similar to other reviews also this one doesn't
report an increase risk of breast cancer after the use of anti-
depressants [35]. So, with the evidence available at this
moment, it is difficult to disentangle the possible effects
of depression and antidepressants on the occurrence of
subsequent cancer. It therefore will also be difficult to
translate these results in preventive interventions.
Summarizing, we believe that this review presents a ten-
dency towards a small and marginally significant associa-
tion between depression and subsequent overall cancer
risk and forwards a stronger increase of breast cancer risk
emerging many years after a previous depression.
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